Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy
Sylvain Simon(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Stanley R. Riddell(University of Washington)
Cited by 15
Related Papers
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <i>In Vivo</i> Antitumor Activity
|Cancer Immunology Research|2014|517
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks
|Immunity|2024|38
Sensitive bispecific chimeric T cell receptors for cancer therapy
|Research Square|2024|1